Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Oct-17 5:11 PM View:  | Larimar Therapeutics, Inc. (LRMR) | 13-Oct-17 | Market Purchase | 10,000 | $3.90 | $38,988.00 | 26% 37.96K to 47.96K | 231% |
| 20-Dec-16 5:02 PM View: | Larimar Therapeutics, Inc. (LRMR) | 19-Dec-16 | Market Purchase | 10,000 | $3.23 | $32,290.00 | 50% 20.0K to 30.0K | 289% |
| 17-Nov-16 5:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 15-Nov-16 | Market Purchase | 10,000 | $3.54 | $35,434.00 | 100% 10.0K to 20.0K | 246% |
| 26-Jul-16 5:09 PM View: | Larimar Therapeutics, Inc. (LRMR) | 22-Jul-16 | Market Purchase | 10,000 | $2.99 | $29,900.00 | 100% 0 to 10.0K | 311% |
| 12-Mar-14 4:52 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-14 | Payment of Exercise | 958 | $56.14 | $53,782.10 | (19%) 5.18K to 4.22K | 6% |
| 12-Mar-14 4:52 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-14 | Acquisition (other) | 730 | -- | -- | 26% 2.84K to 3.57K | |
| 12-Mar-14 4:52 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-14 | Option Exercise | 1,609 | -- | -- | 45% 3.57K to 5.18K | |
| 02-Oct-13 4:23 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Oct-13 | Payment of Exercise | 1,658 | $47.24 | $78,323.90 | (37%) 4.5K to 2.84K | (10%) |
| 02-Oct-13 4:23 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Oct-13 | Option Exercise | 4,451 | -- | -- | 10116% 44 to 4.5K | |
| 17-May-11 9:24 PM View: | Exelixis, Inc. (EXEL) | 15-May-11 | Option Exercise | 3,125 | -- | -- | 22% 14.13K to 17.25K | |
| 15-Feb-11 9:06 PM View: | Exelixis, Inc. (EXEL) | 15-Feb-11 | Option Exercise | 12,500 | -- | -- | 767% 1.63K to 14.13K | |
| 04-Nov-09 5:00 PM View: | Exelixis, Inc. (EXEL) | 02-Nov-09 | Market Sale (Planned) | 2,529 | $6.19 | $15,658.00 | (63%) 4.03K to 1.5K | (151%) |
| 05-Jun-09 5:00 PM View: | Exelixis, Inc. (EXEL) | 03-Jun-09 | Market Sale (Planned) | 10,609 | $5.01 | $53,125.70 | (88%) 12.11K to 1.5K | (204%) |